FIELD: medicine.
SUBSTANCE: invention relates to a medicated product to correct exposure of biological objects to cold, which contains sterilised natural zeolite powder, with particle size 1-2 to 10 mcm mixed with distilled water in the volume rate 1:15. The medicated product is intended for inhalation in an individual's lungs in a daily dosage to 100 mg/kg, throughout no more than 15 days running.
EFFECT: possibility for continuous retention of treatment-and-prophylactic effect.
5 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING INHALATION POWDER | 2008 |
|
RU2372092C1 |
METHOD OF PREPARING STANDARD AEROSOL SAMPLES | 2012 |
|
RU2525427C2 |
METHOD OF SUBSTANCE ANTIOXIDANT ACTIVITY TEST | 2009 |
|
RU2419794C2 |
SORPTION CONTAINER | 2011 |
|
RU2458665C1 |
SORPTION CONTAINER | 2011 |
|
RU2452450C1 |
METHOD OF ASSESSMENT OF TERRITORY ATMOSPHERE ENVIRONMENTAL CONDITION | 2012 |
|
RU2522161C2 |
METHOD OF MEASURING PARAMETERS OF INTERNAL COMBUSTION ENGINE EXHAUST GASES | 2013 |
|
RU2525051C1 |
COMPOSITION FOR BIOLOGICALLY ACTIVE BANDAGE GEL | 2015 |
|
RU2588968C1 |
SORPTION CONTAINER | 2002 |
|
RU2219887C1 |
METHOD FOR NUTRICIENT ENRICHMENT | 2004 |
|
RU2307522C2 |
Authors
Dates
2010-03-20—Published
2008-04-25—Filed